Unclassified renal cell carcinoma

A report of 56 cases

Antonio Lopez-Beltran, Ziya Kirkali, Rodolfo Montironi, Ana Blanca, Ferran Algaba, Marina Scarpelli, Kutsal Yorukoglu, Arndt Hartmann, Liang Cheng

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective To evaluate the clinicopathological features and outcomes of 56 patients with unclassified renal cell carcinoma (RCC) meeting 2004 World Health Organization diagnostic criteria. Patients and Methods Urological pathology files of the participating institutions were reviewed and cases of unclassified RCC that met the inclusion criteria were retrieved. Nuclear grade, pT status, tumour size, regional lymph node involvement, distant metastases, coagulative tumour necrosis, mucin and sarcomatoid differentiation were evaluated in radical nephrectomy or nephron-sparing specimens. Significant factors in univariate analysis were then assessed by a multivariate analysis of independent prognostic factors using Cox proportional hazard regression analysis. Results Fifty-six cases met the histological criteria for unclassified RCC. Thirty-four (61%) cases were categorized as unrecognizable cell type (mean overall survival 47 months; median 36 months), 20 (36%) as composites of recognized types (mean overall survival 36 months; median 26 months), and two (4%) (mean survival 16 months; median 16 months) as pure sarcomatoid morphology without recognizable epithelial elements. Cox multivariate analysis showed nuclear grade (P= 0.020), stage (P < 0.001), tumour coagulative necrosis (P= 0.018), tumour size (P < 0.001), microvascular invasion (P < 0.001) and tumour histotype (P= 0.028) to be independent predictors of disease-free survival, with tumour size being the most significant (hazard ratio [HR] 9.068, 95% confidence interval [CI] 3.231-25.453). Nuclear grade (P= 0.026), stage (P < 0.001), tumour coagulative necrosis (P < 0.001), tumour size (P= 0.044), microvascular invasion (P < 0.001), tumour recurrence after surgery (P < 0.001) and tumour histotype (P= 0.056) were independent predictors of cancer-specific survival, with tumour recurrence after surgery being the most significant (HR 14.713, 95% CI 5.329-40.622). Conclusion The prognosis of patients with unclassified RCC seems to be related to clinicopathological features known to be relevant in common forms of RCC.

Original languageEnglish
Pages (from-to)786-793
Number of pages8
JournalBJU International
Volume110
Issue number6
DOIs
StatePublished - Sep 2012

Fingerprint

Renal Cell Carcinoma
Neoplasms
Necrosis
Survival
Multivariate Analysis
Confidence Intervals
Recurrence
Nephrons
Mucins
Nephrectomy
Disease-Free Survival
Lymph Nodes
Regression Analysis
Pathology
Neoplasm Metastasis

Keywords

  • pathology
  • prognosis
  • renal cell carcinoma
  • survival
  • unclassified
  • WHO classification

ASJC Scopus subject areas

  • Urology

Cite this

Lopez-Beltran, A., Kirkali, Z., Montironi, R., Blanca, A., Algaba, F., Scarpelli, M., ... Cheng, L. (2012). Unclassified renal cell carcinoma: A report of 56 cases. BJU International, 110(6), 786-793. https://doi.org/10.1111/j.1464-410X.2012.10934.x

Unclassified renal cell carcinoma : A report of 56 cases. / Lopez-Beltran, Antonio; Kirkali, Ziya; Montironi, Rodolfo; Blanca, Ana; Algaba, Ferran; Scarpelli, Marina; Yorukoglu, Kutsal; Hartmann, Arndt; Cheng, Liang.

In: BJU International, Vol. 110, No. 6, 09.2012, p. 786-793.

Research output: Contribution to journalArticle

Lopez-Beltran, A, Kirkali, Z, Montironi, R, Blanca, A, Algaba, F, Scarpelli, M, Yorukoglu, K, Hartmann, A & Cheng, L 2012, 'Unclassified renal cell carcinoma: A report of 56 cases', BJU International, vol. 110, no. 6, pp. 786-793. https://doi.org/10.1111/j.1464-410X.2012.10934.x
Lopez-Beltran A, Kirkali Z, Montironi R, Blanca A, Algaba F, Scarpelli M et al. Unclassified renal cell carcinoma: A report of 56 cases. BJU International. 2012 Sep;110(6):786-793. https://doi.org/10.1111/j.1464-410X.2012.10934.x
Lopez-Beltran, Antonio ; Kirkali, Ziya ; Montironi, Rodolfo ; Blanca, Ana ; Algaba, Ferran ; Scarpelli, Marina ; Yorukoglu, Kutsal ; Hartmann, Arndt ; Cheng, Liang. / Unclassified renal cell carcinoma : A report of 56 cases. In: BJU International. 2012 ; Vol. 110, No. 6. pp. 786-793.
@article{628ea6037bf949e69a6ef66e2fa5963e,
title = "Unclassified renal cell carcinoma: A report of 56 cases",
abstract = "Objective To evaluate the clinicopathological features and outcomes of 56 patients with unclassified renal cell carcinoma (RCC) meeting 2004 World Health Organization diagnostic criteria. Patients and Methods Urological pathology files of the participating institutions were reviewed and cases of unclassified RCC that met the inclusion criteria were retrieved. Nuclear grade, pT status, tumour size, regional lymph node involvement, distant metastases, coagulative tumour necrosis, mucin and sarcomatoid differentiation were evaluated in radical nephrectomy or nephron-sparing specimens. Significant factors in univariate analysis were then assessed by a multivariate analysis of independent prognostic factors using Cox proportional hazard regression analysis. Results Fifty-six cases met the histological criteria for unclassified RCC. Thirty-four (61{\%}) cases were categorized as unrecognizable cell type (mean overall survival 47 months; median 36 months), 20 (36{\%}) as composites of recognized types (mean overall survival 36 months; median 26 months), and two (4{\%}) (mean survival 16 months; median 16 months) as pure sarcomatoid morphology without recognizable epithelial elements. Cox multivariate analysis showed nuclear grade (P= 0.020), stage (P < 0.001), tumour coagulative necrosis (P= 0.018), tumour size (P < 0.001), microvascular invasion (P < 0.001) and tumour histotype (P= 0.028) to be independent predictors of disease-free survival, with tumour size being the most significant (hazard ratio [HR] 9.068, 95{\%} confidence interval [CI] 3.231-25.453). Nuclear grade (P= 0.026), stage (P < 0.001), tumour coagulative necrosis (P < 0.001), tumour size (P= 0.044), microvascular invasion (P < 0.001), tumour recurrence after surgery (P < 0.001) and tumour histotype (P= 0.056) were independent predictors of cancer-specific survival, with tumour recurrence after surgery being the most significant (HR 14.713, 95{\%} CI 5.329-40.622). Conclusion The prognosis of patients with unclassified RCC seems to be related to clinicopathological features known to be relevant in common forms of RCC.",
keywords = "pathology, prognosis, renal cell carcinoma, survival, unclassified, WHO classification",
author = "Antonio Lopez-Beltran and Ziya Kirkali and Rodolfo Montironi and Ana Blanca and Ferran Algaba and Marina Scarpelli and Kutsal Yorukoglu and Arndt Hartmann and Liang Cheng",
year = "2012",
month = "9",
doi = "10.1111/j.1464-410X.2012.10934.x",
language = "English",
volume = "110",
pages = "786--793",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Unclassified renal cell carcinoma

T2 - A report of 56 cases

AU - Lopez-Beltran, Antonio

AU - Kirkali, Ziya

AU - Montironi, Rodolfo

AU - Blanca, Ana

AU - Algaba, Ferran

AU - Scarpelli, Marina

AU - Yorukoglu, Kutsal

AU - Hartmann, Arndt

AU - Cheng, Liang

PY - 2012/9

Y1 - 2012/9

N2 - Objective To evaluate the clinicopathological features and outcomes of 56 patients with unclassified renal cell carcinoma (RCC) meeting 2004 World Health Organization diagnostic criteria. Patients and Methods Urological pathology files of the participating institutions were reviewed and cases of unclassified RCC that met the inclusion criteria were retrieved. Nuclear grade, pT status, tumour size, regional lymph node involvement, distant metastases, coagulative tumour necrosis, mucin and sarcomatoid differentiation were evaluated in radical nephrectomy or nephron-sparing specimens. Significant factors in univariate analysis were then assessed by a multivariate analysis of independent prognostic factors using Cox proportional hazard regression analysis. Results Fifty-six cases met the histological criteria for unclassified RCC. Thirty-four (61%) cases were categorized as unrecognizable cell type (mean overall survival 47 months; median 36 months), 20 (36%) as composites of recognized types (mean overall survival 36 months; median 26 months), and two (4%) (mean survival 16 months; median 16 months) as pure sarcomatoid morphology without recognizable epithelial elements. Cox multivariate analysis showed nuclear grade (P= 0.020), stage (P < 0.001), tumour coagulative necrosis (P= 0.018), tumour size (P < 0.001), microvascular invasion (P < 0.001) and tumour histotype (P= 0.028) to be independent predictors of disease-free survival, with tumour size being the most significant (hazard ratio [HR] 9.068, 95% confidence interval [CI] 3.231-25.453). Nuclear grade (P= 0.026), stage (P < 0.001), tumour coagulative necrosis (P < 0.001), tumour size (P= 0.044), microvascular invasion (P < 0.001), tumour recurrence after surgery (P < 0.001) and tumour histotype (P= 0.056) were independent predictors of cancer-specific survival, with tumour recurrence after surgery being the most significant (HR 14.713, 95% CI 5.329-40.622). Conclusion The prognosis of patients with unclassified RCC seems to be related to clinicopathological features known to be relevant in common forms of RCC.

AB - Objective To evaluate the clinicopathological features and outcomes of 56 patients with unclassified renal cell carcinoma (RCC) meeting 2004 World Health Organization diagnostic criteria. Patients and Methods Urological pathology files of the participating institutions were reviewed and cases of unclassified RCC that met the inclusion criteria were retrieved. Nuclear grade, pT status, tumour size, regional lymph node involvement, distant metastases, coagulative tumour necrosis, mucin and sarcomatoid differentiation were evaluated in radical nephrectomy or nephron-sparing specimens. Significant factors in univariate analysis were then assessed by a multivariate analysis of independent prognostic factors using Cox proportional hazard regression analysis. Results Fifty-six cases met the histological criteria for unclassified RCC. Thirty-four (61%) cases were categorized as unrecognizable cell type (mean overall survival 47 months; median 36 months), 20 (36%) as composites of recognized types (mean overall survival 36 months; median 26 months), and two (4%) (mean survival 16 months; median 16 months) as pure sarcomatoid morphology without recognizable epithelial elements. Cox multivariate analysis showed nuclear grade (P= 0.020), stage (P < 0.001), tumour coagulative necrosis (P= 0.018), tumour size (P < 0.001), microvascular invasion (P < 0.001) and tumour histotype (P= 0.028) to be independent predictors of disease-free survival, with tumour size being the most significant (hazard ratio [HR] 9.068, 95% confidence interval [CI] 3.231-25.453). Nuclear grade (P= 0.026), stage (P < 0.001), tumour coagulative necrosis (P < 0.001), tumour size (P= 0.044), microvascular invasion (P < 0.001), tumour recurrence after surgery (P < 0.001) and tumour histotype (P= 0.056) were independent predictors of cancer-specific survival, with tumour recurrence after surgery being the most significant (HR 14.713, 95% CI 5.329-40.622). Conclusion The prognosis of patients with unclassified RCC seems to be related to clinicopathological features known to be relevant in common forms of RCC.

KW - pathology

KW - prognosis

KW - renal cell carcinoma

KW - survival

KW - unclassified

KW - WHO classification

UR - http://www.scopus.com/inward/record.url?scp=84865523067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865523067&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2012.10934.x

DO - 10.1111/j.1464-410X.2012.10934.x

M3 - Article

VL - 110

SP - 786

EP - 793

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 6

ER -